<SEC-DOCUMENT>0001292814-25-002116.txt : 20250516
<SEC-HEADER>0001292814-25-002116.hdr.sgml : 20250516
<ACCEPTANCE-DATETIME>20250516060339
ACCESSION NUMBER:		0001292814-25-002116
CONFORMED SUBMISSION TYPE:	6-K/A
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20250630
FILED AS OF DATE:		20250516
DATE AS OF CHANGE:		20250516

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BRF S.A.
		CENTRAL INDEX KEY:			0001122491
		STANDARD INDUSTRIAL CLASSIFICATION:	MEAT PACKING PLANTS [2011]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				000000000
		STATE OF INCORPORATION:			D5
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15148
		FILM NUMBER:		25956836

	BUSINESS ADDRESS:	
		STREET 1:		AV DAS NACOES UNIDAS 14401 22ND-25TH
		STREET 2:		FLOORS TORRE A2 VILA GERTRUDES 04794-000
		CITY:			SAO PAULO SP BRAZIL
		STATE:			D5
		ZIP:			00000
		BUSINESS PHONE:		551123225377

	MAIL ADDRESS:	
		STREET 1:		AV DAS NACOES UNIDAS 14401 22ND-25TH
		STREET 2:		FLOORS TORRE A2 VILA GERTRUDES 04794-000
		CITY:			SAO PAULO SP BRAZIL
		STATE:			D5
		ZIP:			00000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BRF-BRASIL FOODS S.A.
		DATE OF NAME CHANGE:	20090708

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PERDIGAO SA
		DATE OF NAME CHANGE:	20000823
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K/A
<SEQUENCE>1
<FILENAME>brf20250515_6ka.htm
<DESCRIPTION>6-K/A
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; background-color: white"><FONT STYLE="font-size: 18pt"><B>FORM
6-K/A<BR>
U.S. SECURITIES AND EXCHANGE COMMISSION<BR>
</B></FONT><B><FONT STYLE="font-size: 10pt">Washington, D.C. 20549</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; background-color: white"><B>REPORT OF
FOREIGN PRIVATE ISSUER<BR>
PURSUANT TO RULE 13a-16 OR 15d-16 OF THE<BR>
<FONT STYLE="text-transform: uppercase">SECURITIES EXCHANGE ACT OF 1934</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; background-color: white"><B>dated&nbsp;May
15, 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; background-color: white"><B>Commission
File Number 1-15148</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; background-color: white"><FONT STYLE="font-size: 18pt"><B>BRF
S.A.<BR>
</B></FONT><FONT STYLE="font-size: 10pt">(Exact Name as Specified in its Charter)</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; background-color: white"><FONT STYLE="font-size: 10pt"><B>N/A</B><BR>
</FONT><FONT STYLE="font-size: 13.5pt">&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">(Translation of Registrant&rsquo;s
Name)</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; background-color: white"><B>14401 AV. DAS NACOES UNIDAS 22ND FLOOR</B><BR>
<B>CHAC SANTO ANTONIO 04730 090-S&atilde;o Paulo &ndash; SP, Brazil</B><BR>
<FONT STYLE="font-size: 13.5pt">&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">(Address of principal executive
offices) (Zip code)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in; background-color: white">Indicate by
check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.</P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0 0 12pt; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Form
20-F&nbsp;</FONT><FONT STYLE="font-family: Wingdings">x</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;
Form 40-F&nbsp;</FONT><FONT STYLE="font-family: Wingdings">o</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in; background-color: white">Indicate by
check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation&nbsp;S-T<BR>
Rule&nbsp;101(b)(1):&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in; background-color: white">Indicate by
check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation&nbsp;S-T<BR>
Rule&nbsp;101(b)(7):&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in; background-color: white">Indicate by
check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information
to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.</P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0 0 12pt; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Yes&nbsp;</FONT><FONT STYLE="font-family: Wingdings">o</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;
No&nbsp;</FONT><FONT STYLE="font-family: Wingdings">x</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in; background-color: white">If &ldquo;Yes&rdquo;
is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):&nbsp;Not applicable.</P>

<P STYLE="font: 13.5pt Times New Roman, Times, Serif; margin: 0 0 10pt; background-color: white">&nbsp;</P>



<P STYLE="font: 13.5pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 13.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; background-color: white">*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in; background-color: white">This material
includes certain forward-looking statements that are based principally on current expectations and on projections of future events
and financial trends that currently affect or might affect the Company&rsquo;s business, and are not guarantees of future performance.&nbsp;
These forward-looking statements are based on management&rsquo;s expectations, which involve a number of known and unknown risks,
uncertainties, assumptions and other important factors, many of which are beyond the Company&rsquo;s control and any of which could
cause actual financial condition and results of operations to differ materially fom those set out in the Company&rsquo;s forward-looking
statements.&nbsp; You are cautioned not to put undue reliance on such forward-looking statements.&nbsp; The Company undertakes
no obligation, and expressly disclaims any obligation, to update or revise any forward-looking statements.&nbsp; The risks and
uncertainties relating to the forward-looking statements in this Report on Form 6-K, including Exhibit 1 hereto, include those
described under the captions &ldquo;Forward-Looking Statements&rdquo; and &ldquo;Item 3. Key Information &mdash; D. Risk Factors&rdquo;
in the Company&rsquo;s annual report on Form 20-F for the year ended December 31, 2024.</P>

<P STYLE="font: 13.5pt Times New Roman, Times, Serif; margin: 0 0 10pt; background-color: white">&nbsp;</P>



<P STYLE="font: 13.5pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 13.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; background-color: white">SIGNATURES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in; background-color: white">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf
by the undersigned, thereunto duly authorized.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:&nbsp;May&nbsp;15, 2025</FONT></TD>
    <TD COLSPAN="3" STYLE="padding-right: 0.7pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding-right: 0.7pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding-right: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BRF S.A.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding-right: 0.7pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding-right: 0.7pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; padding-right: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Fabio Luis Mendes Mariano</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 42%; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="width: 3%; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="width: 7%; padding-right: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: </FONT></TD>
    <TD STYLE="width: 48%; padding-right: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;Fabio Luis Mendes Mariano</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="padding-right: -9.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </FONT></TD>
    <TD STYLE="padding-right: 0.7pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Chief Financial and Investor Relations Officer</P>
        <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD></TR>
</TABLE>
<P STYLE="font: 13.5pt Times New Roman, Times, Serif; margin: 0 0 10pt; background-color: white">&nbsp;</P>

<P STYLE="font: 13.5pt Times New Roman, Times, Serif; margin: 0 0 10pt; background-color: white">&nbsp;</P>




<P STYLE="font: 13.5pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 13.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 13.5pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>

<P STYLE="font: 13.5pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; background-color: white"><B>EXHIBIT INDEX</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 16%; border-bottom: Black 1pt solid; padding-right: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit</B></FONT></TD>
    <TD STYLE="width: 84%; border-bottom: Black 1pt solid; padding-right: 0.7pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Description of Exhibit</B></P>
        <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-bottom: 6pt"><A HREF="ex99-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></A></TD>
    <TD STYLE="padding-right: 0.7pt; padding-bottom: 6pt"><A HREF="ex99-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JOINT MATERIAL FACT</FONT></A></TD></TR>
</TABLE>
<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 10pt">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>

<P STYLE="font: 10pt/120% Arial,sans-serif; margin: 0 0 7pt; text-align: center"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify"><B>This business combination involves the securities
of a Brazilian company. The business combination is subject to disclosure requirements of Brazil that are different from those of the
United States. Financial statements included in the document, if any, have been prepared in accordance with foreign accounting standards
that may not be comparable to financial statements of United States companies.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify"><B>It may be difficult for you to enforce your
rights and any claim you may have arising under the U.S. federal securities laws, since the issuer is located in Brazil, and some or all
of its officers and directors may be residents of Brazil. You may not be able to sue a Brazilian company or its</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify"><B>officers or directors in a Brazilian court
for violations of the U.S. securities laws. It may be difficult to compel a Brazilian company and its affiliates to subject themselves
to a U.S. court&rsquo;s judgment.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify"><B>You should be aware that the issuer may purchase
securities otherwise than under the exchange offer, such as in open market or privately negotiated purchases.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 51%; padding-right: 5.4pt; padding-bottom: 7pt; padding-left: 5.4pt; font: 10pt/120% Arial,sans-serif; text-align: center"><IMG SRC="brf202505156k_001.jpg" ALT="A blue and black logo&#10;&#10;AI-generated content may be incorrect." STYLE="height: 92px; width: 227px"></TD>
    <TD STYLE="width: 49%; padding-right: 5.4pt; padding-bottom: 7pt; padding-left: 5.4pt; font: 10pt/120% Arial,sans-serif; text-align: center"><IMG SRC="brf202505156k_002.jpg" ALT="" STYLE="height: 68px; width: 142px"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt/120% Arial,sans-serif; padding-right: 5.4pt; padding-bottom: 7pt; padding-left: 5.4pt; text-align: center"><B>MARFRIG
    GLOBAL FOODS S.A.</B><BR>
    Publicly Traded Company<BR>
    <FONT STYLE="line-height: 120%">CNPJ/MF n&ordm; 03.853.896/0001-40<BR>
    NIRE 35.300.341.031</FONT></TD>
    <TD STYLE="font: 10pt/120% Arial,sans-serif; padding-right: 5.4pt; padding-bottom: 7pt; padding-left: 5.4pt; text-align: center"><B>BRF S.A.<BR>
</B>Publicly Traded Company<BR>
CNPJ/MF n&ordm; 01.838.723/0001-27<BR>
NIRE 42.300.034.240</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0 0 7pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0 0 7pt; text-align: center"><B>JOINT MATERIAL FACT</B></P>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0 0 7pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0 0 7pt; text-align: justify"><B>MARFRIG GLOBAL FOODS S.A.</B> (&ldquo;<B>Marfrig</B>&rdquo;)
and <B>BRF S.A.</B> (&ldquo;<B>BRF</B>&rdquo; and, together with Marfrig, the &ldquo;<B>Companies</B>&rdquo;), in compliance with Article
157, Paragraph 4, of Law No. 6,404, dated December 15, 1976 (&ldquo;<B>Brazilian Corporations Law</B>&rdquo;), CVM Resolution No. 44,
dated August 23, 2021 (&ldquo;<B>CVM Resolution 44</B>&rdquo;), and CVM Resolution No. 78, dated March 29, 2022 (&ldquo;<B>CVM Resolution
78</B>&rdquo;), hereby, through this joint material fact, inform their shareholders and the market in general that, on the present date,
the Plan of Merger of BRF S.A. Shares by Marfrig Global Foods S.A.&rdquo; (&ldquo;<B>Plan of Merger</B>&rdquo;) was executed, which sets
forth the terms and conditions applicable to the Merger (as defined below).</P>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0 0 7pt; text-align: justify">In addition to the execution of the Plan
of Merger, at meetings held on the date hereof, (i) the Board of Directors of Marfrig (&ldquo;<B>Marfrig Board</B>&rdquo;) approved the
convening of Marfrig's extraordinary general meeting, to be held on the first call on June 18, 2025, at 11:00 a.m. S&atilde;o Paulo, Brazil
time (&ldquo;<B>Marfrig EGM</B>&rdquo;); and (ii) the Board of Directors of BRF (&ldquo;<B>BRF Board</B>&rdquo;) approved the convening
of BRF's extraordinary general meeting, to be held on the first call on June 18, 2025, at 9:00 a.m. S&atilde;o Paulo, Brazil time (&ldquo;<B>BRF
EGM</B>&rdquo; and, together with the Marfrig EGM, the &ldquo;<B>EGMs</B>&rdquo;), which will deliberate on the Merger. The information
and documents related to the convening of the EGMs, including the management proposal and the Plan of Merger, will be duly and timely
disclosed by the Companies, in accordance with the terms and deadlines of applicable legislation and regulations.</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0 0 7pt; text-align: justify">Pursuant to the provisions of CVM Resolution
78, the main terms and conditions of the Merger are described below.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt/120% Arial, Helvetica, Sans-Serif; margin-top: 14pt; margin-bottom: 7pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 34pt">1</TD><TD STYLE="text-align: justify">Identification of the companies involved in the transaction and a brief description of the activities
they undertake</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 7pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 34pt"><FONT STYLE="font-size: 10.5pt; line-height: 120%"><B>1.1</B></FONT></TD><TD STYLE="text-align: justify"><U>Marfrig Global Foods S.A.</U> Marfrig is a publicly traded company, registered as category &ldquo;A&rdquo;
issuer of securities with the Brazilian Securities and Exchange Commission (&ldquo;<B>CVM</B>&rdquo;) and listed on B3 S.A. &ndash; Brasil,
Bolsa, Balc&atilde;o (&ldquo;<B>B3</B>&rdquo;), and admitted for trading on the &ldquo;Novo Mercado&rdquo; B3 segment (&ldquo;<B>Novo
Mercado</B>&rdquo;), with its registered office located in the city of S&atilde;o Paulo, State of S&atilde;o Paulo, at Avenida Queiroz
Filho, No. 1,560, Block 5 (Sabi&aacute; Tower), 3rd floor, Room 301, Vila Hamburguesa, ZIP Code 05319-000, registered with the National
Registry of Legal Entities of the Ministry of Finance (&ldquo;<B>CNPJ/MF</B>&rdquo;) under No. 03.853.896/0001-40. Marfrig's corporate
purpose includes the following activities: (i) operation of slaughterhouses, including the slaughtering of cattle, horses, pigs, goats,
sheep, poultry, and buffalo, and the industrialization and commercialization of animal products and by-products, edible or otherwise,
including, but not limited to, the industrialization and commercialization of leather products and by-products, in its own or third-party
establishments; (ii) purchase, sale, distribution, representation, import, and export of food products in general, including alcoholic
and non-alcoholic beverages and others; (iii) purchase and sale of live cattle, horses, pigs, goats, sheep, poultry, and buffalo; (iv)
provision of actual labor to other companies; (v) engagement in agricultural, livestock, and forestry activities; (vi) participation as
a partner or shareholder in any commercial or civil company; (vii) distribution and commercialization of food products in general; (viii)
production, distribution, and commercialization of soaps, washing preparations, disinfectants, fabric softeners, and other hygiene and
cleaning products; (ix) cogeneration, production, and commercialization of energy and biodiesel; (x) participation in the financial market,
as well as in the carbon credit market; (xi) commercialization and production of products derived from legumes and vegetables, including
all their derivatives and substitutes, feed, preserves, canned goods, and fats; (xii) transportation of its products and third-party products;
representation and other related ventures necessary for the corporate purposes; (xiii) breeding, rearing, and fattening of live cattle,
horses, pigs, goats, sheep, poultry, and buffalo in its own and third-party establishments; (xiv) import and export of products related
to the agricultural and livestock activities, including embryos and others; (xv) provision of actual labor to other companies; (xvi) provision
of services to third parties for the breeding, care, management, fattening, and transportation of live cattle, horses, pigs, goats, sheep,
poultry, and buffalo; (xvii) technical tests and analyses; (xviii) production of pharmaceutical and chemical products of animal origin;
(xix) production of unspecified organic chemical products; and (xx) ecological restoration services.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 7pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 34pt"><FONT STYLE="font-size: 10.5pt; line-height: 120%"><B>1.2</B></FONT></TD><TD STYLE="text-align: justify"><U>BRF S.A.</U> BRF is a publicly traded company, registered as category &ldquo;A&rdquo; issuer of securities
with the CVM, listed on B3, and admitted for trading on the Novo Mercado, with its registered office located in the city of Itaja&iacute;,
State of Santa Catarina, at Rua Jorge Tzachel, 475, Fazenda Neighborhood, ZIP Code 88301-600, registered with the CNPJ/MF under No. 01.838.723/0001-27.
BRF's corporate purpose includes the following activities: (i) industrialization, retail and wholesale commercialization, and exploitation
of food products in general, primarily those derived from animal protein and food products that use the cold chain as a support and distribution
method; (ii) industrialization and commercialization of animal feed, nutrients, and food supplements; (iii) provision of food services
in general; (iv) industrialization, refining, and commercialization of vegetable oils, fats, and dairy products; (v) engagement, conservation,
storage, ensiling, and commercialization of grains, their derivatives, and by-products; (vi) retail and wholesale commercialization of
consumption and production goods, including commercialization
of equipment and vehicles for the development of its logistical activity; (vii)&nbsp;export and import of production and consumption goods;
(viii)&nbsp;provision of services of transportation, logistics and distribution of cargo and food products in general; (ix)&nbsp;participation
as a partner or shareholder in other companies, aiming at the broadest fulfillment of its corporate purpose; (x)&nbsp;participation in
projects necessary to the operation of the its business; (xi)&nbsp;industrialization, on its own or by third-party establishments, commercialization,
export and import of pharmaceutical and chemical products of animal origin; (xii)&nbsp;production and commercialization of organic chemical
products of animal origin; (xiii)&nbsp;production, distribution and export of pharmaceutical inputs of animal origin; (xiv) intermediation
and agency of services and businesses in general, except for real estate; (xv) provision of administrative services to third parties;
and (xvi) provision of laboratory analysis and technical services to third parties.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 34pt; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt/120% Arial, Helvetica, Sans-Serif; margin-top: 14pt; margin-bottom: 7pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 34pt">2</TD><TD STYLE="text-align: justify">Description and purpose of the transaction</TD></TR></TABLE>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 34pt; text-align: justify">The transaction set forth in the Plan
of Merger consists of the acquisition by Marfrig of all BRF shares (other than the shares held by Marfrig) on the Closing Date, in exchange
for the issuance to BRF shareholders (except Marfrig) of common shares of Marfrig, in accordance with the Exchange Ratio (as defined below),
resulting in the transfer of BRF's shareholder base to Marfrig (&quot;<B>Merger</B>&quot;). Upon the completion of the Merger, BRF will
become a wholly-owned subsidiary of Marfrig.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt/120% Arial, Helvetica, Sans-Serif; margin-top: 14pt; margin-bottom: 7pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 34pt">3</TD><TD STYLE="text-align: justify">Main benefits, costs and risks of the transaction</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 7pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 34pt"><FONT STYLE="font-size: 10.5pt; line-height: 120%"><B>3.1</B></FONT></TD><TD STYLE="text-align: justify"><U>Benefits</U>. The Merger aims to create a global food company based on a multiprotein platform, with
a strong presence in both domestic and international markets, portfolio diversification, scale, efficiency, and sustainability, providing
significant benefits to both Companies, their shareholders, customers, suppliers, employees, and other stakeholders, generating operational,
financial, and strategic synergies.</TD></TR></TABLE>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 34pt; text-align: justify">Additionally, the Companies believe
that the Merger allows for the simplification and optimization of the administrative and corporate structure of the economic group to
which they belong, eliminating or reducing redundant costs, and improving or facilitating access to the capital necessary for the development
of their business plans.</P>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 0.5in; text-align: justify">In this regard, the Companies believe
that the Merger will have significant strategic value added, driving global consolidation of their businesses and strengthening their
brands through a robust multi-protein platform, including, among others, (i) solidifying their position as leaders in the global food
market; (ii) strategic expansion into new markets, maximizing growth opportunities and commercial synergies, including cross-selling initiatives;
and (iii) increasing the scale and diversification of their operations, enhancing resilience and mitigating risks associated with sector
seasonality and macroeconomic variables.</P>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 0.5in; text-align: justify">The Companies have identified potential
synergies in the context of the Merger. These synergies include:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 7pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 34pt"></TD><TD STYLE="width: 34pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">an increase in revenues and a reduction in costs estimated of R$485 million per year, resulting from the
acceleration of cross-selling opportunities, including volumes and other commercial fronts through logistical capillarity and brand strength,
and supply chain synergies (raw materials, packaging, and inputs);</TD></TR></TABLE>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 7pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 34pt"></TD><TD STYLE="width: 34pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">a reduction in expenses estimated of R$320 million per year, resulting from the commercial and logistics
structure, the consolidation of a single operational system, and the optimization of the corporate structure; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 7pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 34pt"></TD><TD STYLE="width: 34pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">resulting fiscal optimization estimated of R$3 billion, net present value.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 7pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 34pt"><FONT STYLE="font-size: 10.5pt; line-height: 120%"><B>3.2</B></FONT></TD><TD STYLE="text-align: justify"><U>Costs</U>. <FONT STYLE="line-height: 120%">It is estimated that the total costs of the Merger will
be approximately R$ 24 million, including expenses for publications, auditors, appraisers, legal and financial advisors, and other professionals
retained to assist in the Merger, not including any potential outlays incurred to obtain any third-party approvals required for the implementation
of the Merger.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 7pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 34pt"><FONT STYLE="font-size: 10.5pt; line-height: 120%"><B>3.3</B></FONT></TD><TD STYLE="text-align: justify"><U>Risks</U></TD></TR></TABLE>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 34pt; text-align: justify">The management of the Companies does
not foresee any material risks for the implementation of the Merger beyond those typically associated with the Companies' daily activities
and consistent with their size and operations.</P>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 34pt; text-align: justify">However, it is noted that the market
value of the shares issued by Marfrig and BRF remains subject to market fluctuations through the Closing Date and, in the case of Marfrig
shares, also after the completion of the Merger, due to a series of factors outside the control of the Companies.</P>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 34pt; text-align: justify">Moreover, the success of the Merger
will depend, in part, on the group's ability to reduce expenses and optimize processes as a result of the simplification of its corporate
structure and consolidation of its businesses. However, there is no certainty that such cost reductions and process optimizations will
be successful. If these objectives are not achieved successfully, the expected benefits from the Merger may not fully materialize or may
take longer than anticipated to be realized.</P>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 34pt; text-align: justify">The materialization of any of the above
risks or the partial or total failure of the growth opportunities and synergies mapped out within the scope of the Merger could adversely
impact the economic and financial situation, operational results, and the trading price of the securities issued by the Companies.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt/120% Arial, Helvetica, Sans-Serif; margin-top: 14pt; margin-bottom: 7pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 34pt">4</TD><TD STYLE="text-align: justify">Exchange Ratio for Shares</TD></TR></TABLE>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 34pt; text-align: justify">As a result of the Merger, BRF shareholders
(except Marfrig) will receive 0.8521 common shares of Marfrig for each 1 (one) common share of BRF held on the Closing Date, in accordance
with the terms of the Plan of Merger (&quot;<B>Closing Date</B>&quot; and &quot;<B>Exchange Ratio</B>,&quot; respectively).</P>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 34pt; text-align: justify">The negotiation and determination of
the Exchange Ratio took into account the distribution of dividends and/or interest on own capital in the gross amount of (i) R$3,520,000,000.00
(three billion, five hundred and twenty million reais) by BRF; and (ii) R$2,500,000,000.00 (two billion, five hundred million reais) by
Marfrig, in both cases, to be authorized following the payment of the right of withdrawal of any Dissenting Shareholders (as defined below)
and up to and including the Closing Date (collectively, &quot;<B>Permitted Distributions</B>&quot;). Accordingly, any Dissenting Shareholders
who exercise their right of withdrawal shall not be entitled to receive the Permitted Distributions.</P>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 34pt; text-align: justify">The Exchange Ratio shall be adjusted
exclusively (i) in the event of stock splits, consolidations, or in-kind dividend payments of either Company; and/or (ii) according to
the methodology set forth in Annex 3.1.5. of the Plan of Merger. In accordance with the methodology described in Annex 3.1.5 of the Plan
of Merger, any payments made by the Companies upon exercising the right of withdrawal will proportionally reduce the Permitted Distributions
by an equivalent amount applied to both Companies.</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 34pt; text-align: justify">The replacement of the shares issued
by BRF underlying the American Depositary Shares representing common shares issued by BRF within the scope of the Merger will be carried
out in accordance with the terms of the respective deposit agreement.</P>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 34.05pt; text-align: justify">Any fractional common shares of
Marfrig resulting from the Merger will be aggregated into whole numbers and subsequently sold on the B3 spot market after the completion
of the Merger, in accordance with a communication to be timely disclosed to the market by Marfrig. The proceeds from such sales will be
made available, net of fees, to the former BRF shareholders who are entitled to the respective fractions, proportionally to their participation
in each share sold.</P>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 34pt; text-align: justify">Marfrig will not issue shares in connection
with the Merger corresponding to any BRF shares that may be held in treasury, which will be canceled by BRF up to the Closing Date.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt/120% Arial, Helvetica, Sans-Serif; margin-top: 14pt; margin-bottom: 7pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 34pt">5</TD><TD STYLE="text-align: justify">Criteria for Determining the Exchange Ratio</TD></TR></TABLE>

<P STYLE="font: bold 10pt/120% Arial, Helvetica, Sans-Serif; margin: 14pt 0 7pt 34pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-weight: normal">Considering
that the Merger is a transaction involving the controlling company, Marfrig, and the controlled company, BRF, in compliance with CVM Guidance
Opinion No. 35, of September 1, 2008, the BRF Board established a special independent committee of BRF (&ldquo;</FONT>BRF Independent
Committee<FONT STYLE="font-weight: normal">&rdquo;), whose function was to negotiate the Exchange Ratio and other terms and conditions
of the transaction involving the Companies and submit its recommendation to the BRF Board. The BRF Independent Committee was advised by
Citigroup as its financial advisor, and a fairness opinion was issued by Citigroup Global Markets Inc. in connection with the Merger.</FONT></P>

<P STYLE="font: bold 10pt/120% Arial, Helvetica, Sans-Serif; margin: 14pt 0 7pt 34pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-weight: normal">In
addition, the Marfrig Board established a special independent committee of Marfrig (&ldquo;</FONT>Marfrig Independent Committee<FONT STYLE="font-weight: normal">&rdquo;
and, together with the BRF Independent Committee, &ldquo;</FONT>Independent Committees<FONT STYLE="font-weight: normal">&rdquo;), which
was responsible for the initial proposal and subsequent negotiation of the Exchange Ratio with the BRF Independent Committee.</FONT></P>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 34pt; text-align: justify">In this regard, the Exchange Ratio
was exhaustively negotiated between the Independent Committees, taking into account the fair value of the Companies, as well as the assumptions
described in the Plan of Merger, and their recommendation was approved by both Independent Committees in a meeting held on May 15, 2025.
In issuing their favorable recommendation for the transaction, the Independent Committees considered, with the assistance of their external
advisors, a variety of factors, such that the Exchange Ratio was not determined based on a single criterion, but on a combination of various
criteria.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt/120% Arial, Helvetica, Sans-Serif; margin-top: 14pt; margin-bottom: 7pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 34pt">6</TD><TD STYLE="text-align: justify">Main active and passive elements that will form each portion of the assets, in case of a spin-off.</TD></TR></TABLE>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 34pt; text-align: justify">Not applicable, given that the Merger
does not involve a spin-off.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt/120% Arial, Helvetica, Sans-Serif; margin-top: 14pt; margin-bottom: 7pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 34pt">7</TD><TD STYLE="text-align: justify">Whether the transaction has been or will be submitted for approval to Brazilian or foreign authorities</TD></TR></TABLE>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 34pt; text-align: justify">Not applicable.</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt/120% Arial, Helvetica, Sans-Serif; margin-top: 14pt; margin-bottom: 7pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 34pt">8</TD><TD STYLE="text-align: justify">In operations involving controlling, controlled, or commonly controlled companies, the share exchange
ratio calculated in accordance with Article 264 of Law No. 6,404/1976</TD></TR></TABLE>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 34pt; text-align: justify; text-indent: 0in">Pursuant to Article
264 of the Brazilian Corporations Law, an appraisal report was prepared containing the calculation of the Exchange Ratio of the shares
held by the non-controlling shareholders of BRF, based on the market value of the shareholders&rsquo; equity of Marfrig and BRF, evaluated
in accordance to the same criteria and as of December 31, 2024, at market prices (&ldquo;<B>Article 264 Appraisal Report</B>&rdquo;).</P>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 34pt; text-align: justify; text-indent: 0in">If the exchange ratio
resulting from the Merger were calculated based on the Article 264 Appraisal Report, 2.26148341591578 common shares of Marfrig would be
delivered for each 1 (one) common share of BRF held by the shareholders of BRF (excluding Marfrig).</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt/120% Arial, Helvetica, Sans-Serif; margin-top: 14pt; margin-bottom: 7pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 34pt">9</TD><TD STYLE="text-align: justify">Applicability of the right of withdrawal and the value of the refund</TD></TR></TABLE>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 34pt; text-align: justify">Pursuant to Articles 137 and 252, paragraph
2, of the Brazilian Corporations Law, the Merger, if approved, will entitle the Companies&rsquo; shareholders to exercise a right of withdrawal.</P>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 34pt; text-align: justify">The right of withdrawal will be guaranteed
to the shareholders of each of the Companies who (i) are holders of shares issued by Marfrig or BRF, as the case may be, uninterruptedly
from the date of disclosure of this joint material fact (inclusive) through the Closing Date; (ii) do not vote in favor of the Merger,
abstain from voting, or do not attend the Marfrig EGM or the BRF EGM, as the case may be; and (iii) expressly manifest their intention
to exercise the right of withdrawal within 30 (thirty) days from the date of publication of the minutes of the Marfrig EGM or the BRF
EGM, as the case may be (&ldquo;<B>Dissenting Shareholders</B>&rdquo;).</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 7pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 34pt"><FONT STYLE="font-size: 10.5pt; line-height: 120%"><B>9.1</B></FONT></TD><TD STYLE="text-align: justify"><U>Dissenting Shareholders of Marfrig</U>. Pursuant to the Brazilian Corporations Law, the Dissenting
Shareholders of Marfrig will be entitled to the right of withdrawal at the value of the shareholders&rsquo; equity per share of Marfrig,
as approved by the Marfrig ordinary general meeting held on March 31, 2025, which corresponds to R$3.32 (three <I>reais</I> and thirty-two
cents) per share, without prejudice to the right to request a special balance sheet, in accordance with Article 45 of the Brazilian Corporations
Law.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 7pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 34pt"><FONT STYLE="font-size: 10.5pt; line-height: 120%"><B>9.2</B></FONT></TD><TD STYLE="text-align: justify"><U>Dissenting Shareholders of BRF</U>. Pursuant to the Brazilian Corporations Law, the Dissenting Shareholders
of BRF shall be entitled to the right of withdrawal at the value of the shareholders&rsquo; equity per share of BRF as of December 31,
2024, as approved by the BRF ordinary general meeting held on March 31, 2025, which corresponds to R$9.43 (nine <I>reais</I> and forty-three
cents) per share, without prejudice to the right to request a special balance sheet, in accordance with Article 45 of the Brazilian Corporations
Law.</TD></TR></TABLE>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 34pt; text-align: justify; text-indent: 0in">As described in item
8 above, it is observed that the exchange ratio calculated based on the Article 264 Appraisal Report is more advantageous to the shareholders
of BRF when compared to the Exchange Ratio.</P>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 34pt; text-align: justify; text-indent: 0in">Therefore, the provisions
of Article 264, paragraph 3, of the Brazilian Corporations Law will apply and the Dissenting Shareholders of BRF may opt between (i) the
reimbursement value fixed in accordance with Article 45 of the Brazilian Corporations Law, that corresponds to R$9.43 (nine <I>reais</I>
and forty-three cents) per share, as mentioned above; or (ii) the shareholders&rsquo; equity per share of BRF, determined based on the
Article 264 Appraisal Report, which corresponds to R$19.89 (nineteen <I>reais</I> and eighty-nine cents.) per share.</P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 7pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 34pt"><FONT STYLE="font-size: 10.5pt; line-height: 120%"><B>9.3</B></FONT></TD><TD STYLE="text-align: justify"><U>Reconsideration</U>. The Companies reserve the right to convene general meetings of the Companies to
ratify or reconsider the Merger, if they determine that the payments in connection with shareholder withdrawal rights to the Dissenting
Shareholders who exercised such rights would jeopardize the financial stability of any of the Companies, in accordance with Article 137,
paragraph 3, of the Brazilian Corporations Law.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt/120% Arial, Helvetica, Sans-Serif; margin-top: 14pt; margin-bottom: 7pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 34pt">10</TD><TD STYLE="text-align: justify">Other relevant information</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 7pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 34pt"><FONT STYLE="font-size: 10.5pt; line-height: 120%"><B>10.1</B></FONT></TD><TD STYLE="text-align: justify"><U>Corporate approvals</U>. The completion of the Merger, which will also be subject to the satisfaction
of the Condition Precedent (as defined below) and to the occurrence of the Closing Date, will depend on the performance of the following
acts, all of which are interdependent and must be coordinated to occur on the same date:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 7pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 34pt"></TD><TD STYLE="width: 34pt">(i)</TD><TD STYLE="text-align: justify">BRF EGM to, in this order, (a) approve the Plan of Merger; (b) approve the Merger; (c) ratify the appointment
of the appraiser responsible for preparing the appraisal report of the market value of the BRF shares to be incorporated by Marfrig (&ldquo;<B>Merger
Appraisal Report</B>&rdquo;) and the Article 264 Appraisal Report; (d) approve the Merger Appraisal Report; (e) approve the Article 264
Appraisal Report; and (f) authorize BRF&rsquo;s management to perform all acts necessary for the completion of the Merger, including,
without limitation, the subscription of the common shares to be issued by Marfrig on behalf of the BRF shareholders (other than Marfrig)
on the Closing Date, in accordance with Article 252, paragraph 2, of the Brazilian Corporations Law; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 7pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 34pt"></TD><TD STYLE="width: 34pt">(ii)</TD><TD STYLE="text-align: justify">Marfrig EGM to, in this order, (a) approve the Plan of Merger; (b) approve the Merger; (c) approve the
increase in the share capital of Marfrig, the respective issuance of common shares by Marfrig, as well as the consequent amendment and
consolidation of Marfrig's bylaws, with delegation to Marfrig Board of the powers to confirm the actual number of shares to be issued
by Marfrig, in the event of adjustments to the Exchange Ratio; (d) ratify the appointment of the valuation company responsible for the
preparation of the Merger Appraisal Report; (e) approve the Merger Appraisal Report; (f) approve Appraisal Report 264; and (g) authorize
Mafrig&rsquo;s management to perform all acts necessary for the completion of the Merger.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 7pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 34pt"><FONT STYLE="font-size: 10.5pt; line-height: 120%"><B>10.2</B></FONT></TD><TD STYLE="text-align: justify"><U>Condition Precedent</U>. From the date of execution of the Plan of Merger through the Closing Date
(inclusive), there shall be no occurrence of war, armed conflicts, natural disasters and/or other events (e.g. health emergencies; fires
in manufacturing units) that adversely and materially impact the productive capacity and/or commercialization (including export) of either
Company (&quot;<B>Condition</B>&quot;).</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 7pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 34pt"><FONT STYLE="font-size: 10.5pt; line-height: 120%"><B>10.3</B></FONT></TD><TD STYLE="text-align: justify"><U>Closing</U>. Once the Merger is approved by the EGMs, the Companies and their respective management
shall perform all acts and measures necessary for the implementation of the Merger, including, without limitation, the confirmation of
the occurrence or the waiver of the Condition, as applicable, and the Companies shall disclose the Closing Date to the market in accordance
with applicable legislation and regulations.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 7pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 34pt"><FONT STYLE="font-size: 10.5pt; line-height: 120%"><B>10.4</B></FONT></TD><TD STYLE="text-align: justify"><U>Change of Corporate Name</U>. Additionally, Marfrig informs that it has submitted to the Marfrig EGM
the proposal to approve the change of Marfrig's corporate name <U>from</U> Marfrig Global Foods S.A. <U>to</U> <B>MBRF Global Foods Company
S.A.</B>, subject to the consummation of the Merger.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 7pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 34pt"><FONT STYLE="font-size: 10.5pt; line-height: 120%"><B>10.5</B></FONT></TD><TD STYLE="text-align: justify"><U>Additional Information</U>. In compliance with the provisions of Article 3 of CVM Resolution 78 and
the provisions of CVM Resolution No. 81, of March 29, 2022, the documents related to the Merger and the EGMs are or will be, as applicable,
available to the shareholders of each of the Companies at the registered
office of each of the Companies, as well as on the websites of Marfrig (ri.marfrig.com.br) or BRF (ri.brf-global.com), as the case may
be, of CVM (www.gov.br/cvm) and B3 (www.b3.com.br), and may be consulted by the shareholders of the Companies, in accordance with applicable
regulations.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 34pt; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 7pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 34pt"><FONT STYLE="font-size: 10.5pt; line-height: 120%"><B>10.6</B></FONT></TD><TD STYLE="text-align: justify"><U>Forward-Looking Statements and Projections</U>. This material fact presents projections, estimates,
expectations, and forward-looking statements of the Companies, including the anticipated effects of the Merger. These projections, estimates,
expectations, and forward-looking statements are largely based on current expectations, estimates of future projections, and trends that
affect or may affect the Companies' sectors, market shares, businesses, operations, and results. While the Companies believe that these
estimates and forward-looking statements are based on reasonable assumptions, as described above, they are subject to various risks, uncertainties,
and assumptions outside the control of the Companies, including (without limitation) the risk factors described in items 4.1 to 4.3 of
the reference form of each of the Companies, and are made based on the information currently available to the Companies. The information
presented above reflects the Company's expectations, which are subject to risks and uncertainties, and are estimated and indicative data
that do not constitute a performance promise. These expectations depend on market conditions, the economic scenario, and the sectors in
which the Companies operate. Any change in the perception or assumptions described above may result in actual outcomes differing from
the presented projections.</TD></TR></TABLE>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0 0 7pt; text-align: justify">Additional information regarding the matters
described in this material fact will be promptly disclosed by the Companies in accordance with applicable legislation and regulations.</P>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0 0 7pt; text-align: center">S&atilde;o Paulo, May 15, 2025.</P>

<P STYLE="font: 10pt/120% Arial, Helvetica, Sans-Serif; margin: 0 0 7pt; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; padding-right: 5.4pt; padding-bottom: 7pt; padding-left: 5.4pt; text-align: center; line-height: 120%"><B>MARFRIG GLOBAL FOODS S.A.</B></TD>
    <TD STYLE="width: 51%; padding-right: 5.4pt; padding-bottom: 7pt; padding-left: 5.4pt; text-align: center; line-height: 120%"><B>BRF S.A.</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 7pt; padding-left: 5.4pt; text-align: center; line-height: 120%"><B>Tang David<BR>
</B>Chief Financial Officer and Chief Investor Relations Officer</TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 7pt; padding-left: 5.4pt; text-align: center; line-height: 120%"><B>F&aacute;bio Luis Mendes Mariano<BR>
</B>Chief Financial and Investor Relations Officer</TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><B><I><U>IMPORTANT NOTICE</U></I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><B><I>This communication is not an offering document and does not constitute
an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval.</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><B><I>Investors in American Depositary Shares (&ldquo;ADSs&rdquo;) of BRF
and holders of common shares of BRF are urged to read the informational document regarding the merger between BRF and Marfrig because
it will contain important information.</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><B><I>U.S. holders of common shares of BRF are urged to read any informational
document or other materials prepared by BRF for common shareholders of BRF regarding the merger because they will contain important information.
BRF expects to submit copies of these documents to the U.S. Securities and Exchange Commission (&ldquo;SEC&rdquo;) when they are available,
and investors and security holders may obtain free copies of these documents and other documents filed by the Companies with the SEC at
the SEC&rsquo;s website at www.sec.gov.</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><B><I>A copy of any informational documents prepared for holders of ADRs
or U.S. holders of common shares of BRF (when available) may also be obtained for free from Marfrig.</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><B><I>This communication contains forward-looking statements. These statements
are statements that are not historical facts and are based on the current view and estimates of management of BRF and Marfrig of future
economic circumstances, industry conditions, company performance and financial results. The words &ldquo;anticipates,&rdquo; &ldquo;believes,&rdquo;
&ldquo;estimates,&rdquo; &ldquo;expects,&rdquo; &ldquo;plans&rdquo; and similar expressions, as they relate to the Companies, are intended
to identify forward-looking statements.</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><B><I>Statements regarding the structure and timing of any merger between
the Companies, business strategies, future synergies, future costs and future liquidity of the Companies, and pro forma results of operations
and financial condition of the Companies are examples of forward-looking statements.</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"><B><I>Such statements reflect the current views of management and
are subject to a number of risks and uncertainties, including economic and market conditions in Brazil and globally, conditions in the
industry of the Companies, any regulatory actions relating to the merger, the ability of the Companies to achieve projected synergies
and the risk factors outlined by each of the Companies in their filings with the SEC and the Brazilian Comiss&atilde;o de Valores Mobili&aacute;rios
(CVM). There is no guarantee that the expected events, trends or results will actually occur.</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><B><I>Any changes in the assumptions and factors on which these forward-looking
statements are based could cause actual results to differ materially from current expectations.</I></B></P>

<P STYLE="font: 10pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt; text-align: left"><B>&nbsp;</B></P>



<P STYLE="font: 8.5pt/9.2pt Times New Roman, Times, Serif; margin: 10.1pt 0 0; text-align: center"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>brf202505156k_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 brf202505156k_001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !S 1P# 2(  A$! Q$!_\0
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MW'/>OHK3-2MM7TZ"^LY!)!.H92/Y'WJJE-P)A-2+=%,EE2")Y96"1H"S,3P
M.]?/WC?Q]>Z]KCG3[N>WL(24A6-RN_U8X]:5.FYO0<YJ*/H2BO*O@M?W=Z^K
M?:[J:?:(]OF.6QUZ9KU6E./*[!&7,KA1114E!1110 445Q_Q(\72>%="4V>/
MMMTQ2(D9V#NV*<4Y.R$W97.N+JIPS 'W-+7S9IVB^)O&+S7=JMS>%#\\LDN!
MGT!)_05ZM\*M-UZPL+W^W)+E4\P1PP3G)7'4C/8Y_2M)TE%;D1GS/8[ZBBFR
M;A&VS[^#CZUD:#J*^>M.U7Q2?'D0,UZ;PW6V2)BVW;NY&.F,5]"U<X<A,9<P
M4445!04444 %%%% !5+6+G[%HU[<9P8H78?4 U=K,\20M/X:U*-/O-;/C_OD
MTUN#/#OA?HPUWQG%+<KOCM@;B3(X+9X_4UZM\2H?,\-)(.L<ZG\""*X[X%QK
MYNK2?Q[8U_#FO2?%-B=1\-WL"C+^7N7ZCG^E7B=6T<LX<U"275,POAI?B;19
MK0GYX),@?[)_^OFNSKQ;PIKIT#64G?)@D&R8#T]?PKV6">*ZA2:"19(W&593
MD&N>G*Z,\!652DH]4.=PB,['"J,D^U>%ZQ>?VAK%W==I96(^G:O1O'GB6.PT
M]]/MI ;N<;6VG[B]\^YKS;3+1K_4[:U49,LBK^&>:BJ[NR./,JO/.-*)[)I-
MC')X6M;*= T;VJQNI'4%>:\*T:!_#'Q2MK7) M[[RB?5"<?R-?1"*$15'11@
M5XAXLMO,^-<$48YDN("<>N!7;0=KKR/4E'E2\CW&O-/C=_R+EC_U\_TKTNO-
M/C=_R+EC_P!?/]*FE\:+J?"SR_3O#-QJOAJ_U2TR[6,@$D0')0C[P^E=1\*O
M&G]BZB-)OI,6-TW[MF/$4A_H:WO@>H;3=65@"IE4$'O\M<K\2O!;>&-6^V62
M$:==,2F/^63]U_PKH<E*3A(Q2<4I(Z7XN>-<!O#^G2<GF[=3V[)_C7GS>&;B
M'PA_;UQF.*2=8H$(Y<<Y;Z5?\"^$I_&.N_OR_P!BA(>YE)Y;_9SZFO1OC#!%
M:^!K:"!%CBCN$5%48  !XHNH-00[.=Y,R/@9]_5_I'_6NR\9^/[#P@BQ.IN;
MZ092!3C ]6/85Q?P/<1_VR[=%6,G_P >KA9S<^,O&I5G_?7UUL!/1%S@?@!4
MN"E4=]D-2<8*QT\OQKUTS;H[6R2//W"I/ZYKHK3XT6\VA7,TUFL>I0J"D)?Y
M)>>QZC'I77:5X#\/Z39+;QZ=!*0,-)*@9G/J2:\Z^*W@:QT:VBU?281!$T@C
MFA7[H)Z,/2I3IR=K#:G%7N=EX \=S^,I+Q9[..V^SA2-CELYSZ_2L.[^+\UE
MXIETR;3H!;Q71@:;S#D+NP6Q5'X&_P#'QJW^['_6N!\41M+XSU2-!EGO'4#W
M+52IQ<VA.<N5,]%UKXU^5?M#HU@DT*MM\Z9B-WN .U4OC3,T_P#84C#!>%W(
M'8G;77:%\*_#]AIL27]FMY=%09))2?O=\#L*Y3XWHL4^BQH,*L4B@>@&VE!P
MYTHCES<KYC#\*?$ZX\*Z(FFP:;#,JNS[VD()S7H<?Q"N'^'3^)?L,0E64Q^3
MO.W[V.M9'PV\&:#K7@Z"[U'3HI[AI7!=B<D \=ZU/B'I-EHGPSN[/3K=8+=9
M%8(O3);)I3<'*UM;A'F4;W,W2_C/;RZ=>SZG9K#+#M$,43Y,I.?7IC%7? _Q
M(N_%OB"6RFL88(5A,BE7);@BO-_AYX3B\6:^T-VS"TMT\R7:<%N<!<]J]PTG
MPAHF@S_:-,T^.";84,BDY(]Z*BA&Z2U"#E+5G#6/Q8N+KQ7'IQTFV7S+G[.9
M0YW8W8STKT?5]7L]#TV6^U"4101#DGJ3V '<U\\:-_R4:W_[")_]#-==\;-7
MDDU6RTM6(ABC\YU]6/ _2G*DG)) IM1;8:K\;;YYV&E6$,4(/#3DLQ_ <"K&
M@?&J5[I(M<M(Q"YP9X,_)[E?2KWPS^'^FOH4&KZK;)=7%R-\:2#*QIVX]371
M>)_AWHNMZ9*L%G#:W:J3%-$NW![ @=12;I)\M@2FU>YSD/Q?ENO%":;;Z? ]
MM)<^2DWF'++G&[%>HU\O^&XVB\7:;&XPR7:*P]"&KZ@J:T%%JQ5.3DM0HHHK
M$T"FR(LL;(XRK @CVIU% 'D?PZB/AGXC:QH=Q\OFJ3%G@, <C'X']*];(R,'
MH:XOQQX4O+^_L==T$+_:UDX^4G:)4],_YZUV%K))-:Q231&&5E!>,G.T]Q6D
MWS6D3%6T/&_%FC-HNNS1!<0R'S(C_LGM^%9]MJE]91E+6[FB0]51R!7L/B3P
M]!XAT\PR$),G,4F/NG_"O*-2\.:GI4QCN+20@'AT7<K?0UQ3@XNZ/!Q>&G1F
MY0V?8S7=I'+NQ9CR23DFNU^&VC-/?R:G*O[N ;(R>['K^0_G61H7@W4=8G7?
M"]O;9^:61<<>P[FO6M/L(-,L8K6U3;%&, >ON:=.#O=FF PLI3]I-:(LUY%X
M<M_^$G^,>HZJHW6MBQ(;L2!L7^6?PKT7Q4VJ?V#<1Z)!YM[,/+0E@H3/5LGT
MJKX)\+1^%-!2U)#W4A\RXD'\3^GT%=D7RQ;/9:NT=%7FGQN_Y%RQ_P"OG^E>
MEUQ'Q2\.ZCXCT6T@TN 321S[V!8+@8]Z5-VFKCFKQ9A? W_D'ZK_ -=4_E7H
MVM:1:Z[I4^GWJ;H9EQ[J>Q'N*X[X5>&=4\-V>H)JMN(6FD5D <-D >U=_3J/
MWVT*"]VS,KPWX>M/#.CQ:?9C*KR[D<R-W)KDOC1_R)T7_7TG\C7H5<=\3M!O
M_$/AJ.TTR$33"=7*E@O SZTH/WTV.2]VR.0^"4?FIK<?]]$7\]U<+I5TWA?Q
MM#-=(1]BN\2KWP#@_I7JOPJ\*ZMX:;43JML(?.";,.&SC.>GUIOQ!^&3>(+E
MM4T=DCO6'[V)^%E]P>QK?GCSM/9F7*^5=T>@6=[;ZA:1W-G,DT$@RKH<@UYM
M\9O$%JND1:+%(KW,DJR2*ISY:KTSZ9-<'%X/\9V$A@M[#4(LG!\ICM/X@XK;
M@^$.L2:)=WEX0=1('D6X<$DYY+-TZ4HPA!W;&Y2DK)&E\#?^/C5O]V/^M<5J
M_P#R4:Z_["1_]#KTWX5>%-6\-3:BVJVPA$RH$PX;.,YZ5S&H_#OQ'/XUGOX[
M$&V>^\T/YJ_=W9SC/I5*4>>3N2XOE1[:.@KQ_P".?_'WI'^Y)_,5[ .@KSCX
MJ^$]7\2W&G-I5L)EA5P^7"XR1CK]*PHM*:;-:BO'0T?A%_R(-O\ ]=I/YU+\
M5_\ D0+W_>3_ -"JS\.M&O=!\(PV6HQ>5<+([%0P/!/'(J3X@Z1>:YX0NK+3
MXO-N'92J[@,X//)HNO:7\PM[EC@?@;_R$=6_ZY1_S->Q'H:\V^%7A+5_#5YJ
M,FJVPA6:- A#ALD$YZ5Z2>AHK-.;:"FK1/FS1O\ DHUO_P!A$_\ H9KIOC7I
M\D/B.TO<'RKB#9GMN4]/R-&F_#OQ';^-(;^2Q MEO3*7\U?N[B<XS7JWBCPU
M9^*M(>QO,KSNCE4?-&WJ*VE42FF9J#<6CGOA;XEL]3\+VNG^:BWMFGE-$3@E
M1T8>HQ72>(M?LO#NDS7=],J!5.Q,_-(W8 =Z\3U+X5^)M+N3]D@%V@/RRP.
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M6C626FGVZ00)T5!^I]35NLZD^=W+A'E5@HHHK,L**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
IHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>brf202505156k_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 brf202505156k_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !5 +(# 2(  A$! Q$!_\0
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M&O6AF=K1110(**** "BBO.OC%XLF\.>%DM+.0QWNHLT2NIP4C ^<CWY _&@
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MAP20O;*9);5G+JR#J5)Y!'7&3FO)?#&NW'AOQ'9:K;L0T$@+J/XTZ,OXC(H
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M<#6?A_PO:,0QB5T) ZE505D_ +_D<M0_[![?^C$K>_:$_P"/30?]^;^25@_
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LJ4M#MA3@M4C9HHHKF-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
